期刊文献+

32例胰、肾同期联合移植的近期疗效 被引量:7

Short-term follow-up of 32 simultaneous pancreas-kidney transplantation
原文传递
导出
摘要 目的报告32例胰、肾同期联合移植(SPK)的近期结果及经验。方法为合并尿毒症的27例1型糖尿病和5例2型糖尿病患者施行SPK,其中胰液膀胱引流(BD)术式2例,改进的胰液空肠引流(ED)术式30例。术后早期采用他克莫司、霉酚酸酯及皮质激素预防排斥反应,同时以抗淋巴细胞球蛋白或抗CD25单克隆抗体诱导治疗。结果32例手术均获得成功,术后随访2~12个月,1例术后9周死于肺部感染,死亡时肾功能正常,另1例术后6个月死于急性心肌梗死,死亡时移植胰、肾功能正常,其余患者目前仍存活;术后(12.7±8.1)d空腹血糖恢复正常,(8.3±4.5)d停用胰岛素,(8.4±7.8)d血肌酐恢复正常。术后发生手术相关并发症有出血、移植胰切口感染、上消化道出血、右股静脉血栓形成和淋巴漏;其它并发症有药物不良反应、肺部感染,采用BD术式者并发代谢性酸中毒和镜下血尿;4例发生移植肾急性排斥反应,均经活检证实。结论SPK治疗糖尿病并发尿毒症的近期疗效满意,ED术式更符合正常生理。 Objective To summarize the short-term results of simultaneous pancreas-kidney transplantation (SPK) at a single-center in China. Methods SPK was performed in 32 consecutive patients from Jan. 2000 to July 2005. All patients had long-standing insulimdependent diabetes mellitus (IDDM) and subsequent renal failure. Bladder drainage (BD) of exocrine secretion was used in the first 2 cases and enteric drainage (ED) in last 30 patients. The patients were treated with quadruple therapy, which included antilymphocyte globulin (ALG) or anti-CD25 monoclonal antibody induction therapy, prednisone, tacrolimus and mycophenolat mofetil (MMF). Results SPK was successfully applied to all cases. All patients have achieved excellent renal function and euglycemia, and no further insulin treatment was needed in 8. 3 ± 4.5 days posttransplant. The mean hospital stay was 51.4 ± 21.3 days. Two patients died due to lung cytomegalovirus infection and secondary sepsis 9 weeks and to acute myocardial infarct 6 months after operation, respectively. The death occurred with functioning grafts. Four biopsyproven renal rejection episodes occurred in 6 to 12 months postoperation. Main complications included wound infections in the side of pancreatic graft, peripancreatitis, and hemorrhage. Conclusion SPK is a effective treatment option for selected patients with type I diabetes mellitus and approaching end-stage renal disease. El) might be a more physiological and prior procedure than BD. The combination of tacrolimus and MMF can be used as a preferred, maintenance immunosuppressive in SPK.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2006年第1期36-39,共4页 Chinese Journal of Organ Transplantation
基金 教育部留学回国人员科研基金(No.1998679) 教育部高校中青年骨干教师基金(教技司2000143)资助
关键词 胰腺 移植 治疗结果 Pancreas Kidney Trans plantation Treatment outcome
  • 相关文献

参考文献10

  • 1明长生,沙波,曾凡军,陈知水,文志向,林正斌,张伟杰,夏穗生.胰液膀胱引流式胰、肾联合移植二例报告[J].中华器官移植杂志,2001,22(1):27-29. 被引量:19
  • 2明长生,沙波,曾凡军,陈知水,文志向,张伟杰,林正斌,陈忠华,夏穗生.改良的胰液空肠引流式胰、肾一期联合移植(附2例报道)[J].中华器官移植杂志,2001,22(4):218-220. 被引量:23
  • 3Gruessner AC,Sutherland DER.Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.Clin Transplant,2005,19:433-455.
  • 4Drognitz O,Benz S,Pfeffer F,et al.Long-term follow-up of 78simultaneous pancreas-kidney transplants at a single-center institution in Europe.Transplantation,2004,78:1802-1808.
  • 5明长生.胰、肾联合移植术式的选择[J].中华器官移植杂志,2005,26(3):186-188. 被引量:17
  • 6Blanchet P,Droupy S,Eschwege P,et al.Urodynamic testing predicts long-term urological complication following simultaneous pancreas-kidney transplantation.Clin Transplant,2003,17:26-31.
  • 7Terasaki PI,eds.Clinical transplants 2003.Los Angeles:UCLA Immunogenetics Center,2004.21-51.
  • 8Kaufman DB,Salvalaggio PRO.Immunosuppression for pancreas transplantation.Curr Opin Organ Transplant,2005,10:169-175.
  • 9明长生.胰腺与胰肾联合移植免疫抑制剂的应用[J].中华器官移植杂志,2004,25(2):125-128. 被引量:11
  • 10Dieterle CD,Schmauss S,Veitenhansl M,et al.Glucose metabolism after pancreas transplantation:cyclosporine versus tacrolimus.Transplantation,2004,77:1561-1565.

二级参考文献58

  • 1明长生(综述),夏穗生(审校).临床胰腺移植的进展[J].中国实用外科杂志,1994,14(12):741-743. 被引量:15
  • 2Hariharan S, Pirsch JD, Lu CY, et al. Pancreas after kidney transplantation. J Am Soc Nephrol, 2002, 13:1109-1118.
  • 3Guessner A, Sutherland DER. Pancreas transplant outcome for United States (US) and none-US reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002. In: Cecka JM,Terasaki PI, eds. Clinical transplants 2002. Los Angeles: UCLA Tissue Typing Laboratory, 2003. 41 75 .
  • 4Larson TS, Bohorquez H, Rea DJ, et al. Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation, 2004,77:838-884.
  • 5明长生.胰腺移植与胰肾联合移植[A].杨春明 主编.外科学原理与实践[C].北京:人民卫生出版社,2003.573-580.
  • 6Blanchet P, Droupy S, Eschwege P, et al. Urodynamic testing predicts long-term urological complication following simultaneous pancreas-kidney transplantation. Clin Transplant, 2003, 17: 2631.
  • 7Black P, Plaskon LA, Miller J, et al. Cystoenteric conversion and reduction cystoplasty for treatment of bladder dysfunction after pancreas transplantation. Transplantation, 2003, 170:1913-1917.
  • 8Sutherland DER, Gruessner A. Pancreas transplant results in the UNOS United States of America registry compared with nonUSA data in the international registry. In: Terasaki P, Cecka M, eds. Clinical transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, 1996. 47.
  • 9Corry RJ, Chakrabarti P, Shapiro R, et al. Comparison of enteric versus bladder drainage in pancreas transplantation.Transplant Proc, 2001, 33:1647.
  • 10Stratta RJ, Shokouh-Amiri MH, Egidi MF, et al. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolatemofetil-based immunosuppression. Clin Transplant, 2003, 17(Suppl 9) :69-77.

共引文献45

同被引文献63

  • 1Zhong-Hua Klaus Chen.Progress in pancreas transplantation and combined pancreas-kidney transplantation[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):17-23. 被引量:8
  • 2张树栋,马潞林,王国良,侯小飞,罗康平,赵磊.胰肾联合移植术后并发十二指肠瘘的处理[J].肝胆胰外科杂志,2005,17(4):302-304. 被引量:2
  • 3于立新,余玉明,邓文锋,徐健,付绍杰,杜传福,王亦斌,叶桂荣,刘小友,苗芸,李川江,叶俊生.胰肾联合移植后长期存活患者的临床观察[J].中华泌尿外科杂志,2006,27(7):458-461. 被引量:5
  • 4明长生.临床胰腺和胰、肾联合移植的现状[J].中华器官移植杂志,2006,27(11):699-701. 被引量:3
  • 5Kaufman DB, Salvalaggio PRO. Immunosuppression for pancreas transplantation. Curt Opin Organ Transplant, 2005,10 : 169- 175.
  • 6Woeste G, Wullstein C, Dette K, et al, Tacrolimus/mycophenolate mofetil vs cyclosporine A/azathioprine after simultaneous pancreas and kidney transplantation: Five-Year results of a randomized study, Transplant Proc, 2002,34:1920- 1921.
  • 7Land W, Malaise J, Sandberg J, et al. Tacrolimus versus cyclosporine in primary simultaneous pancreas kidney tansplantation; preliminary results at 1 year of a large multicenter trial. Transplant Proc,2002,34 : 1911-1912.
  • 8Martins L, Pedroso S, Henriques AC, et al, Simultaneous pancreas-kidney transplantation: five-year results from a single center, Transplant Proc, 2006,38 : 1929-1932.
  • 9Freise CE, Kang SM, Feng S, et al, Experience with steroid free maintenance immunosuppression in simultaneous pancre as-kidney transplantation, Transplant Proc, 2004, 36: 1067- 1068.
  • 10Balbontin FG, Kiberd B, Squires J, et al. Tacrolimus monitoring by simplified sparse sampling under the concentration time curve. Transplant Proc,2003,35 : 2445-2448.

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部